Previous close | 42.02 |
Open | 41.54 |
Bid | 41.72 x 1000 |
Ask | 42.77 x 800 |
Day's range | 41.37 - 41.78 |
52-week range | 34.74 - 51.18 |
Volume | |
Avg. volume | 1,247,810 |
Market cap | 9.531B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | 28.81 |
EPS (TTM) | 1.45 |
Earnings date | 05 Feb 2024 - 09 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 47.39 |
Key Insights The projected fair value for Qiagen is US$36.75 based on 2 Stage Free Cash Flow to Equity Current share...
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon and 51-year-old criminal investigation in Georgia // ForenSeq Kintelligence enables identification of distant relatives in genealogy databases, helping to resolve previously unsolvable cases and bringing answers to victims and families // DNA Labs International is one of the first labs to offer this new approach to human identificationVenlo, the Netherlands, and